2025.05.30
At MileCell Bio, we understand the critical role of high-quality hepatocytes in accelerating drug discovery. Our Cryosuspension Primary Hepatocytes are engineered to deliver exceptional post-thaw viability (>80%), ensuring your ADME and toxicology studies start with robust, reliable cells.
Why Choose MileCell’s Suspension Hepatocytes?
✅ Consistent Viability: Every lot undergoes rigorous quality control, guaranteeing >80% viability post-thaw.
✅ Long-Term Stability: Even after 4+ hours of incubation at 37°C, viability remains above 70%
✅ Minimized Variability: Large pooled lots (>300 vials/lot) reduce inter-lot differences, supporting reproducible metabolic activity.
✅ Broad Species Options: Mouse, rat, dog, monkey, and more – all with species- and gender-specific characterization.
Proven Performance
In-house validation shows our hepatocytes maintain stable Phase I/II enzyme activity (e.g., CYP, UGT) post-thaw, critical for accurate intrinsic clearance and metabolite profiling. Whether you’re screening drug candidates or evaluating toxicity, our cells ensure data you can trust.
Custom Solutions Available
Need specific species, gender, or donor configurations? MileCell offers tailored hepatocyte solutions to meet unique research demands.
Tags:
#DrugDiscovery #ADMETox #Hepatocytes #CellViability #BiotechInnovation #PreclinicalResearch #LifeSciences
Learn More:
Visit www.milecell-bio.com
Contact us at Info@milecell-bio.com
Elevate your in vitro studies with hepatocytes designed for precision and reliability. Let MileCell empower your next breakthrough!
